Navi Mumbai, India

Sachin Bhagwan Naykodi


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Sachin Bhagwan Naykodi: Innovator in Pharmaceutical Chemistry**

Introduction

Sachin Bhagwan Naykodi is an accomplished inventor based in Navi Mumbai, India. With a focus on pharmaceutical advancements, he has made significant contributions to the field with two notable patents. His expertise lies in the development of processes aimed at improving medication production.

Latest Patents

Sachin has secured two patents that highlight his innovative approach in pharmaceuticals. The first patent, titled "Process for the preparation of tofacitinib and intermediates thereof," describes a novel method for the synthesis of tofacitinib, a medication essential for treating autoimmune diseases. The second patent, "Process for the preparation and purification of apixaban," presents a refined technique for creating and purifying apixaban, a drug used for blood clots. Both patents demonstrate Sachin's commitment to enhancing drug formulations and therapeutic options.

Career Highlights

Currently, Sachin Naykodi is employed at Glenmark Pharmaceuticals Limited, where he leverages his skills to drive innovation in drug development. His role in the company allows him to work at the forefront of pharmaceutical research and contribute to the production of vital medications.

Collaborations

Throughout his career, Sachin has collaborated with esteemed colleagues such as Shekhar Bhaskar Bhirud and Sushanta Mishra. Together, they combine their expertise to push the boundaries of pharmaceutical research and improve treatment methodologies.

Conclusion

Sachin Bhagwan Naykodi's contributions to the field of pharmaceutical chemistry through his patents highlight the important role of innovation in improving healthcare outcomes. His dedication to advancing drug development at Glenmark Pharmaceuticals Limited marks him as a valuable asset to the industry. With his continued efforts, the future of pharmaceuticals looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…